MetaCap

NANO-X IMAGING LTD (NNOX)

NASDAQ: NNOXHealth CareMedical ElectronicsUSD

0.2251-0.005 (-2.17%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NNOX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$17.73M
EPS (TTM)
-$1.72
52-week range
0.207 – 4.71
Day range
0.2212 – 0.245
Volume / Avg
875.81K / 2.67M
Beta
—
Next earnings
Nov 25, 2026

52-week range

$0.207$4.71

NNOX stock today

On Nov 20, NNOX ended the session at $0.2251, shedding $0.005 (2.17%), versus the S&P 500's 3.70% decline. Trading was light, with 875.81K shares changing hands, about 33% of the average daily volume. Shares are 95.2% below their 52-week high of $4.71, set on Nov 26, 2025 and 8.7% above the 52-week low of $0.207, near the bottom of the past year's range.

NNOX is down 92.0% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 94.8%. NANO-X IMAGING LTD has posted a net loss over the last twelve months (EPS of -$1.72), so its P/E ratio is not meaningful. The company is scheduled to report Sep/2026 results on Nov 25 before the market opens.

Summary generated from market data by MetaCap's automated system. Methodology

About NANO-X IMAGING LTD

Company profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.

Industry
Medical Electronics
CEO
Mr. Erez I. Z. Meltzer
Headquarters
Petah Tikva
Employees
197
IPO year
2020

Financial highlights

Full financials

In fiscal 2025, NANO-X IMAGING LTD generated $13.0 million in revenue, up 15.4% from fiscal 2024, its 4th consecutive year of revenue growth. NANO-X IMAGING LTD reported a net loss of $75.0 million, compared with a loss of $53.5 million a year earlier. Gross margin was -98.2% (down from -94.0%) and operating margin -600.8%.

NANO-X IMAGING LTD annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$13.02M$11.28M$9.90M$8.58M$1.30M
Growth+15.40%+13.91%+15.47%+557.82%—
Net income$-75.02M$-53.52M$-60.78M$-113.24M$-61.80M
EPS (diluted)$-1.16$-0.91$-1.08$-2.17$-1.28

Analyst forecast

Forecast

Consensus (3 analysts)

none

Avg. price target

$4.13+1734.74%

  • Strong buy 0
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 0

Target range

Low $3.00High $5.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Nov 25, 2026

NNOX news

All NNOX news

NANO-X IMAGING LTD peers

Health Care sector
NNOX peer companies
CompanyPrice% ChgMarket capCompare
BFLYButterfly Network Inc. Class A5.40-7.69%$1.44Bvs NNOX
PHGKoninklijke Philips N.V. NY Registry Shares28.61-2.19%$27.97Bvs NNOX
GEHCGE HealthCare Technologies Inc.80.64-1.53%$36.46Bvs NNOX

Indexes, lists and sector

NANO-X IMAGING LTD stock FAQ

What is NANO-X IMAGING LTD's stock price today?

NNOX last traded at $0.2251 as of Nov 20, 4:00 PM EST, down 2.17% on the day. Prices are delayed at least 15 minutes.

When is NANO-X IMAGING LTD's next earnings date?

NANO-X IMAGING LTD is expected to report earnings on Wednesday, November 25, 2026.

Who is NANO-X IMAGING LTD's CEO?

Mr. Erez I. Z. Meltzer is the chief executive officer of NANO-X IMAGING LTD, which has about 197 employees.

What is the NNOX 52-week high?

The 52-week high for NNOX is $4.71 and the 52-week low is $0.207. The stock is currently 95.2% below its high.

Compare NNOX